Anadolu Medical Center
The cost of lung cancer stage 4 treatment in Turkey varies based on the specific treatment plan. An initial consultation with an oncologist can cost around $150, while an MRI of the brain with contrast is approximately $650. PET-CT scans are priced at about $700, and advanced pathological reviews, including genetic and immune markers, can reach $1,250. Targeted therapy is available for $5,700. Chemotherapy courses start at $5,000 for the first cycle, with subsequent cycles costing $4,800 each. The treatment plan is personalized following a detailed assessment by the medical team.
| Turkey | Austria | Spain | |
| Stereotaxic radiosurgery | from $4,500 | from $17,000 | from $12,000 |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Pneumonectomy | from $10,872 | from $50,000 | from $35,000 |
| Lung cancer surgery | from $17,000 | from $42,000 | from $40,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
Author of 40+ peer-reviewed publications in tumor biology/immunology and systemic therapy (immunotherapy and targeted therapy); member of the Turkish Medical Oncology Association and the European Head & Neck Society.
Why patients choose Dr. Bülent Karagöz:
Dr. Eda Tanrikulu is a leading medical oncologist at Anadolu Medical Center, specializing in the use of chemotherapy and new treatment protocols.
Dr. Solak specializes in lung cancer treatment with fellowship training at Hacettepe University Cancer Institute – one of Turkey's leading oncology centers.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.